Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

Clinical trial NCT02690545 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02690545
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma Lymphoma, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Start date: 2016-08-26
Primary completion: 2025-12-16
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.